Squarepoint’s BioTelemetry, Inc. BEAT Stock Holding History

Squarepoint’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20,876	Closed	-$952K	–	3463
2020 Q3	$952K	Buy	20,876 +14,955	+253%	+$625K	0.01%	1028
2020 Q2	$268K	Sell	5,921 -3,679	-38%	-$165K	﹤0.01%	1673
2020 Q1	$370K	Buy	+9,600	New	+$442K	0.01%	1195
2019 Q3	–	Sell	-21,266	Closed	-$1.02M	–	2883
2019 Q2	$1.02M	Buy	+21,266	New	+$1.12M	0.01%	1250
2019 Q1	–	Sell	-4,773	Closed	-$285K	–	2618
2018 Q4	$285K	Buy	+4,773	New	+$287K	﹤0.01%	1531
2017 Q4	–	Sell	-22,108	Closed	-$730K	–	2513
2017 Q3	$730K	Buy	22,108 +8,953	+68%	+$310K	0.01%	837
2017 Q2	$440K	Sell	13,155 -9,556	-42%	-$285K	0.01%	1013
2017 Q1	$657K	Buy	+22,711	New	+$563K	0.02%	753
2016 Q4	–	Sell	-11,899	Closed	-$221K	–	2040
2016 Q3	$221K	Buy	+11,899	New	+$224K	0.01%	865

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Squarepoint's BEAT Position: Q4 2020 in Review

Squarepoint sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 20,876 shares — an estimated $952K sold.

Squarepoint first reported a position in BEAT in Q3 2016 and held it in 9 quarters. The position peaked at $1.02M in Q2 2019. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

Squarepoint reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
Squarepoint sold 20,876 BioTelemetry, Inc. shares in Q4 2020, an estimated $952K.
Squarepoint first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 9 quarters.
Squarepoint's BioTelemetry, Inc. position peaked at $1.02M in Q2 2019.
238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.